RARA CRAFT DATABASE for FDA Medical Devices
510(k)K252711

FDA DEVICE FACTS

Advantage-C™ Ti3D Cervical Interbody Fusion Device

Intelivation Technologies

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 8, 2026PRODUCT CODEODP

Indications for use

The Advantage-C Ti 3D Cervical Interbody Fusion Device is a cervical Interbody fusion device indicated for use in skeletally mature patients with degenerative disc disease (DDD) with/without radicular symptoms at one level from C2-T1. DDD is defined as diagnostic pain with degeneration of the disc confirmed by history and radiographic studies. These patients should have had six weeks of non-operative treatment. The Advantage-C Ti 3D Cervical Interbody Fusion Device is intended for use with supplemental fixation systems and with autogenous bone graft. Advantage-C Ti 3D Cervical Interbody Fusion Device is supplied non-sterile and is intended for one-time use. Prescription Use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026